Delta 9 Cannabis Inc. announced that it has appointed Dr. David Kideckel, PhD, MBA as Executive Vice President, Head of Strategy, Corporate Development & Capital Markets. This is a newly created position to lead the Company’s next phase of growth expansion. David joins Delta 9 after nearly 20 years of combined industry and capital markets experience, most recently serving as Managing Director, Senior Institutional Equity Research Analyst at ATB Capital Markets.